CONTRAVISORY INVESTMENT MANAGEMENT, INC. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$94,000
-1.1%
2,165
-0.9%
0.03%
+11.1%
Q1 2022$95,000
+28.4%
2,185
+21.5%
0.03%0.0%
Q2 2020$74,000
+7.2%
1,799
-1.9%
0.03%
-12.9%
Q1 2020$69,000
+13.1%
1,834
+40.8%
0.03%
+40.9%
Q4 2019$61,000
+8.9%
1,303
-1.4%
0.02%
+4.8%
Q3 2019$56,000
+9.8%
1,321
+2.7%
0.02%
+5.0%
Q2 2019$51,000
-5.6%
1,2860.0%0.02%
-4.8%
Q1 2019$54,000
+10.2%
1,2860.0%0.02%0.0%
Q4 2018$49,000
+4800.0%
1,286
+7044.4%
0.02%
Q4 2017$1,000180.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders